World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
110546
World Ranking
11473
National Ranking
1088

Overview

Jonathan Emberson is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on medicine, with significant contributions to cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, infectious diseases, genetics, and molecular biology.

Their recent scholarly output includes papers published in several prominent venues. Notable publications are:

  • Dexamethasone in Hospitalized Patients with Covid-19, 2020, DiRROS repository (University of Maribor)
  • Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19, 2020, JAMA
  • Empagliflozin in Patients with Chronic Kidney Disease, 2022, New England Journal of Medicine
  • Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19, 2020, New England Journal of Medicine
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials, 2022, The Lancet

Frequent co-authors collaborating with Jonathan Emberson include:

  • Rory Collins
  • Natalie Staplin
  • Richard Haynes
  • Jesús Alegre-Díaz
  • Aldo P. Maggioni

The scientist regularly publishes in high-profile venues such as bioRxiv (Cold Spring Harbor Laboratory), European Heart Journal, The Lancet, The Lancet Diabetes & Endocrinology, and European Heart Journal - Quality of Care and Clinical Outcomes.

Their research covers diverse topics within medicine, focusing particularly on:

  • COVID-19 Clinical Research Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic Associations and Epidemiology
  • Long-Term Effects of COVID-19
  • Blood Pressure and Hypertension Studies

Best Publications

  • RoB 2: a revised tool for assessing risk of bias in randomised trials.

    Jonathan A.C. Sterne;Jelena Savović;Jelena Savović;Matthew J. Page;Roy G. Elbers

  • Dexamethasone in Hospitalized Patients with Covid-19

    P Horby;W S Lim;Emberson

  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

    C Baigent;L Blackwell;J Emberson

  • Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

    Gary Whitlock;Sarah Lewington;Paul Sherliker

  • Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

    Dena Ettehad;Connor A Emdin;Amit Kiran;Simon G Anderson;Simon G Anderson

  • Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

    Colin Baigent;Lisa Blackwell;Rory Collins

  • Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

    Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

    Sarah Lewington;Gary Whitlock;Robert Clarke

  • The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials

    B Mihaylova;J Emberson;L Blackwell

  • Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.

    Sterne Jac.;S Murthy;J V Diaz

  • Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

    Patricia M Kearney;Colin Baigent;Jon Godwin;Heather Halls

  • Interpretation of the evidence for the efficacy and safety of statin therapy.

    Rory Collins;Christina Reith;Jonathan Emberson;Jane Armitage

  • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials

    J Fulcher;R O'Connell;M Voysey

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

    P Horby;M Mafham;L Linsell

  • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

    Kunihiro Matsushita;Bakhtawar K. Mahmoodi;Bakhtawar K. Mahmoodi;Mark Woodward;Jonathan R. Emberson

  • A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache

    Gwendolen Jull;Patricia Trott;Helen Potter;Guy Zito

  • Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

    P Horby;W S Lim;J Emberson;M Mafham

  • Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

    G.L. Moneta

Frequent Co-Authors

Colin Baigent
Colin Baigent University of Oxford
Rory Collins
Rory Collins University of Oxford
Richard Peto
Richard Peto University of Oxford
Peter H. Whincup
Peter H. Whincup St George's, University of London
Peter Horby
Peter Horby University of Oxford
Richard W Morris
Richard W Morris University of Bristol
Thomas Jaki
Thomas Jaki University of Regensburg
Anthony C. Keech
Anthony C. Keech University of Sydney
Mark Woodward
Mark Woodward Imperial College London
Saul N. Faust
Saul N. Faust University Hospital Southampton NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career in the USA but prefer flexible learning options, there are several related online degrees and career paths to explore. For those already holding an RN license, cheap rn to bsn online programs can help you earn a bachelor’s degree affordably and efficiently.

Non-nursing majors interested in advancing into nursing can consider specialized options like online direct entry msn programs for non-nursing majors. These accelerated programs allow career changers to enter the nursing profession quickly.

Many students inquire about online bsn programs for non nurses, which are designed to prepare individuals from diverse backgrounds for the demands of nursing.

Beyond nursing, allied health fields like medical billing and coding also offer strong career prospects. If affordability is key, students often ask: can you get financial aid for medical billing and coding? Many accredited programs do offer aid, making them accessible to a wide range of learners.

Exploring these pathways can open up opportunities in healthcare—both clinical and administrative—through the convenience of online study.

Best Scientists Citing Jonathan Emberson

Trending Scientists